head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2021, vol. 27, issue3
Subject Area: Medicine
DOI: 10.5272/jimab.2021273.3911
Published online: 02 September 2021

Original article

J of IMAB. 2021 Jul-Sep;27(3):3911-3918
Nikolay AtanasovORCID logo Corresponding Autoremail,
Department of Health Management and Health Economics, Faculty of Public Health, Medical University Plovdiv, Bulgaria.

Purpose: The aim of the study is to build a long-term model and conduct a Monte Carlo simulation of the public health expenditure (PHE) of Bulgaria with the gross domestic product (GDP) as an independent variable.
Material/Methods: Statistical models are used for modeling the long-term dependence between the macroeconomic dynamic rows, testing of hypotheses of stationarity (Augmented Dickey-Fuller tests), for serial autocorrelation and others.
Results: There is a well-defined, statistically significant long-term relationship between public health expenditure and gross domestic product. The long-term model of health expenditure has an estimate of the cointegration constant of 1.023 (p-value < 0.05). Monte Carlo simulations are presented with 1 000, 2 000 and 3 000 experiments, generated based on the normal distribution of the input variable.
Conclusions: In the period after the year 1990, a well-defined long-term relationship between public health expenditure and GDP exists. The Monte Carlo simulation can be regarded as a reliable instrument for studying the most likely fluctuations in health expenditure caused by the GDP.

Keywords: health expenditure, Monte Carlo simulation, cointegration, health policy,

pdf - Download FULL TEXT /PDF 1062 KB/
Please cite this article as: Atanasov N. Long-Term Model and Monte Carlo Simulation of the Public Health Expenditure in Bulgaria. J of IMAB. 2021 Jul-Sep;27(3):3911-3918.
DOI: 10.5272/jimab.2021273.3911

Corresponding AutorCorrespondence to: Nikolay Georgiev Atanasov, Department of Health Management and Health Economics, Faculty of Public Health, Medical University Plovdiv; 15A, bul. Vasil Aprilov, Plovdiv, 4000, Bulgaria; E-mail: nik.atanasov@abv.bg

1. Dougherty C. Introduction to Econometrics. 4th Edition. Oxford University Press. April 30, 2011. p.463. [Internet]
2. Watsham TJ, Parramore K. Quantitative Methods in Finance. 1st edition. Cengage Learning EMEA. December 19, 1996: pp.248-257. [Internet]
3. Statistical Yarbook of the Republic of Bulgaria, Chapter: Government Financial Statistic. [in Bulgarian] National Statistical Institute, Sofia, 1991, 1992,1993, 1994, 1995, 1996, 1997, 1998.
4. Data on the Consolidated Fiscal Program (annual) – Expenditure by Functions (1998-2019). Ministry of Finance - R. Bulgaria. December 3, 2020.   [Internet]
5. Report result (nsi.bg); seen on December 3, 2020. [Internet]
6. Watsham TJ, Parramore K. Quantitative Methods in Finance. 1st edition. Cengage Learning EMEA. December 19, 1996: pp.308-312. [Internet]
7. Gerdtham UG, Jönsson B. Chapter 1 - International Comparisons of Health Expenditure: Theory, Data and Econometric Analysis. Handbook of Health Economics. Volume 1, Part A, 2000. Pages 11-53. [Crossref]
8. Hansen P, King A. The determinants of health care expenditure: a cointegration approach. J Health Econ. 1996 Feb;15(1):127–137. [Crossref]
9. Blomqvist AG, Carter RAL. Is health care really a luxury? J Health Econ. 1997 Apr;16(2):207–229. [Crossref]
10. Gerdtham UG, Löthgren M. On stationarity and cointegration of international health expenditure and GDP.  J Health Econ. 2000 Jul;19(4):461-75. [PubMed]
11. Mehrara M, Musai M, Amiri H. The Relationship between Health Expenditure and GDP in OECD Countries Using PSTR. Eur J Econ Fin Admin Sci. 2010 Sep;24:50-58.
12. Murthy VNR, Okunade AA. Determinants of U.S. health expenditure: Evidence from autoregressive distributed lag (ARDL) approach to cointegration. Economic Modelling. 2016 Dec;59:67-73. [Crossref]
13. Feng Y, Watt T, Charlesworth A, Marsden G, Roberts A, Sussex J. What Determines the Health Care Expenditure of High Income Countries? A Dynamic Estimation. Appl Financial Econ. 2017 Nov;4(6):1-16. [Crossref]
14. Jewell T, Lee J, Tieslau M, Strazicich MC.  Stationarity of health expenditures and GDP: evidence from panel unit root tests with heterogeneous structural breaks. J Health Econ. 2003 Mar;22(2):313-23. [PubMed]
15. Behera DK, Dash U. Impact of GDP and tax revenue on health care financing: An empirical investigation from Indian states. Theoretical & Applied Economics. 2017 Summer;24(2(611):249-266. [Internet]
16. Sülkü SN, Caner A. Health care expenditures and gross domestic product: the Turkish case. Eur J Health Econ. 2011 Feb;12(1):29-38. [PubMed]
17. Atilgan E, Kilic D, Ertugrul HM. The dynamic relationship between health expenditure and economic growth: is the health-led growth hypothesis valid for Turkey? Eur J Health Econ. 2017 Jun;18(5):567-574. [PubMed]
18. Gövdeli T. Health Expenditure, Economic Growth, and CO2 Emissions: Evidence from The OECD Countries. Adıyaman Üniversitesi Sosyal Bilimler Enstitüsü Dergisi. 2019 Mar;11(31):488-516. [Crossref]
19. Haseeb M, Kot S, Hussain HI, Jermsittiparsert K. Impact of Economic Growth, Environmental Pollution, and Energy Consumption on Health Expenditure and R&D Expenditure of ASEAN Countries. Energies. 2019; 12(19):3598. [Crossref].

Received: 12 February 2021
Published online: 02 September 2021

back to Online Journal